BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 3, 2017
View Archived Issues
Serum ST2 found to be a predictor of mortality in HIV-infected patients
Read More
Letermovir shows promising phase III results in HCT patients for CMV infection prevention
Read More
AURA-LV study of voclosporin in lupus nephritis meets 48-week remission endpoints
Read More
Achaogen offers overview of R&D programs and introduces new antibiotic clinical candidate
Read More
Series B funding at Omeicos to support new clinical program for OMT-28
Read More
BeiGene initiates pivotal study of BGB-3111 in Chinese patients with mantel cell lymphoma
Read More
Pivotal Chinese study of fruquintinib in colorectal cancer meets endpoints
Read More
Boehringer Ingelheim and Vanderbilt University expand collaboration
Read More
RAGE identified as therapeutic target in COPD
Read More
Synthon and Sanquin enter immuno-oncology collaboration and license agreement
Read More
Otsuka Pharmaceutical agrees to acquire Neurovance
Read More
Phase I results for ODM-204 in mCRPC patients show promise
Read More
Scynexis holds initiation of clinical studies of intravenous SCY-078 following FDA communication
Read More
Carnitine levels indicate risk of myocardial infarction in HIV-infected adults
Read More
Sanofi and MedImmune sign agreement to develop and commercialize MEDI-8897
Read More
Bellus Health and NEOMED Institute enter exclusive worldwide license agreement for BLU-5937
Read More
Sosei submits marketing authorization application in Japan for SO-1105 for oropharyngeal candidiasis
Read More
Phase III study of ataluren in nonsense mutation cystic fibrosis does not meet endpoints
Read More
Integral Molecular and Integrated BioTherapeutics sign collaborate vaccine discovery agreement
Read More
Glucocorticoid receptor expression predicts poor outcomes in mCRPC treated with ARSi
Read More
NEONC Technologies' NEO-212 given U.S. orphan status for intracranial metastases from breast cancer
Read More
PBI-4050 granted U.S. orphan drug designation for the treatment of Alstrom syndrome
Read More
Zhejiang Hisun Pharmaceutical describes novel FGFR inhibitors
Read More
Karyopharm Therapeutics patents PAK and/or NAMPT modulators
Read More
Karus Therapeutics discovers novel PI3K-beta and PI3K-gamma inhibitors
Read More
Changzhou Jiekai Pharmatech describes new ERK2 inhibitors
Read More